| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.023 | 0.9 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.9 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.9 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.9 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.9 |